Ewend, M G <br/><br/>
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 438-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/00002371-200007000-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>Brain Neoplasms--genetics<br/>CD4 Antigens--genetics<br/>Cancer Vaccines--immunology<br/>Female<br/>Immunologic Memory<br/>Injections, Intralesional<br/>Injections, Subcutaneous<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Depletion<br/>Melanoma, Experimental--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Paracrine Communication<br/>Skin Neoplasms--immunology<br/>T-Lymphocyte Subsets--immunology<br/>Transduction, Genetic